Paying users zone. Data is covered by 
.
Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Regeneron Pharmaceuticals Inc. (REGN)
Selected Financial Data
since 2005
Difficulty: Beginner
Income Statement
Regeneron Pharmaceuticals Inc., income statement selected items, long-term trends
USD $ in thousands
| 12 months ended | Revenues | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Dec 31, 2018 | |
|
|
| Dec 31, 2017 | |
|
|
| Dec 31, 2016 | |
|
|
| Dec 31, 2015 | |
|
|
| Dec 31, 2014 | |
|
|
| Dec 31, 2013 | |
|
|
| Dec 31, 2012 | |
|
|
| Dec 31, 2011 | |
|
|
| Dec 31, 2010 | |
|
|
| Dec 31, 2009 | |
|
|
| Dec 31, 2008 | |
|
|
| Dec 31, 2007 | |
|
|
| Dec 31, 2006 | |
|
|
| Dec 31, 2005 | |
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Assets
Regeneron Pharmaceuticals Inc., assets selected items, long-term trends
USD $ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2018 | |
|
| Dec 31, 2017 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2005 | |
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Liabilities and Stockholders’ Equity
Regeneron Pharmaceuticals Inc., liabilities and stockholders’ equity selected items, long-term trends
USD $ in thousands
| Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
| Dec 31, 2017 | |
|
|
|
| Dec 31, 2016 | |
|
|
|
| Dec 31, 2015 | |
|
|
|
| Dec 31, 2014 | |
|
|
|
| Dec 31, 2013 | |
|
|
|
| Dec 31, 2012 | |
|
|
|
| Dec 31, 2011 | |
|
|
|
| Dec 31, 2010 | |
|
|
|
| Dec 31, 2009 | |
|
|
|
| Dec 31, 2008 | |
|
|
|
| Dec 31, 2007 | |
|
|
|
| Dec 31, 2006 | |
|
|
|
| Dec 31, 2005 | |
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Statement of Cash Flows
Regeneron Pharmaceuticals Inc., statement of cash flows selected items, long-term trends
USD $ in thousands
| 12 months ended | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2018 | |
|
|
| Dec 31, 2017 | |
|
|
| Dec 31, 2016 | |
|
|
| Dec 31, 2015 | |
|
|
| Dec 31, 2014 | |
|
|
| Dec 31, 2013 | |
|
|
| Dec 31, 2012 | |
|
|
| Dec 31, 2011 | |
|
|
| Dec 31, 2010 | |
|
|
| Dec 31, 2009 | |
|
|
| Dec 31, 2008 | |
|
|
| Dec 31, 2007 | |
|
|
| Dec 31, 2006 | |
|
|
| Dec 31, 2005 | |
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Per Share Data
Regeneron Pharmaceuticals Inc., per share data selected items, long-term trends
USD $
| 12 months ended | Basic Earnings Per Share 1 | Diluted Earnings Per Share 2 | Dividend Per Share 3 |
|---|---|---|---|
| Dec 31, 2018 | |
|
|
| Dec 31, 2017 | |
|
|
| Dec 31, 2016 | |
|
|
| Dec 31, 2015 | |
|
|
| Dec 31, 2014 | |
|
|
| Dec 31, 2013 | |
|
|
| Dec 31, 2012 | |
|
|
| Dec 31, 2011 | |
|
|
| Dec 31, 2010 | |
|
|
| Dec 31, 2009 | |
|
|
| Dec 31, 2008 | |
|
|
| Dec 31, 2007 | |
|
|
| Dec 31, 2006 | |
|
|
| Dec 31, 2005 | |
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
1, 2, 3 Data adjusted for splits and stock dividends.